Annual report pursuant to Section 13 and 15(d)

Statement of Cash Flows

v3.21.1
Statement of Cash Flows
5 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (4,178,698)
Net gain from investments held in Trust Account (7,668)
Increase in fair value of derivative warrant liabilities 3,471,670
Financing costs related to derivative warrant liabilities 577,150
Changes in operating assets and liabilities:  
Prepaid expenses (333,031)
Accounts payable 10,865
Accrued expenses 3,696
Franchise tax payable 80,598
Net cash used in operating activities (375,418)
Cash Flows from Investing Activities:  
Cash deposited in Trust Account (230,000,000)
Net cash used in investing activities (230,000,000)
Cash Flows from Financing Activities:  
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from note payable to related party 163,000
Repayment of note payable to related party (163,000)
Proceeds received from initial public offering 230,000,000
Proceeds received from private placement 7,250,000
Offering costs paid (5,064,770)
Net cash provided by financing activities 232,210,230
Net increase in cash 1,834,812
Cash - beginning of the period
Cash - end of the period 1,834,812
Supplemental disclosure of non-cash financing activities:  
Offering costs included in accrued expenses 78,500
Deferred underwriting commissions in connection with the initial public offering 8,050,000
Initial value of Class A common stock subject to possible redemption 202,852,290
Change in initial value of Class A common stock subject to possible redemption $ (3,517,110)